These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7838305)

  • 21. Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons.
    Drouet B; Pinçon-Raymond M; Chambaz J; Pillot T
    J Neurochem; 1999 Aug; 73(2):742-9. PubMed ID: 10428072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.
    Heredia L; Helguera P; de Olmos S; Kedikian G; Solá Vigo F; LaFerla F; Staufenbiel M; de Olmos J; Busciglio J; Cáceres A; Lorenzo A
    J Neurosci; 2006 Jun; 26(24):6533-42. PubMed ID: 16775141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of amyloid beta-protein in Alzheimer's disease.
    Barker A
    Lancet; 1992 Oct; 340(8823):850-1. PubMed ID: 1357268
    [No Abstract]   [Full Text] [Related]  

  • 24. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
    Ball MJ
    Neurology; 2000 Jan; 54(2):538. PubMed ID: 10668745
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.
    Perry G
    Med Hypotheses; 1993 Apr; 40(4):257-8. PubMed ID: 8321160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibrillary tangles and Alzheimer's disease.
    Brion JP
    Eur Neurol; 1998 Oct; 40(3):130-40. PubMed ID: 9748670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
    Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
    Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates.
    Huang Y; Herman MM; Liu J; Katsetos CD; Wills MR; Savory J
    Brain Res; 1997 Oct; 771(2):213-20. PubMed ID: 9401741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On keys and correlations in Alzheimer's disease.
    Potter H
    Neurobiol Aging; 1996; 17(6):943-4; discussion 945-7. PubMed ID: 9363810
    [No Abstract]   [Full Text] [Related]  

  • 32. beta-Amyloid neurotoxicity.
    Forloni G
    Funct Neurol; 1993; 8(3):211-25. PubMed ID: 8406141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].
    Buée L; Blum D; Bombois S; Buée-Scherrer V; Caillet-Boudin ML; Colin M; Deramecourt V; Dhaenens CM; Galas MC; Hamdane M; Humez S; Maurage CA; Pasquier F; Sablonnière B; Schraen-Maschke S; Sergeant N
    Therapie; 2010; 65(5):401-7. PubMed ID: 21144474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
    Grace EA; Rabiner CA; Busciglio J
    Neuroscience; 2002; 114(1):265-73. PubMed ID: 12207971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.